会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • ANTIDIABETIC ORAL INSULIN-BIGUANIDE COMBINATION
    • 抗生素口服胰岛素 - 双胍组合
    • WO2006017541A2
    • 2006-02-16
    • PCT/US2005/027499
    • 2005-08-03
    • EMISPHERE TECHNOLOGIES, INC.ARBIT, EhudGOLDBERG, Michael, M.DINH, Steven
    • ARBIT, EhudGOLDBERG, Michael, M.DINH, Steven
    • A61K38/28
    • A61K38/28A61K31/155A61K2300/00
    • Pharmaceutical dosage forms, comprising insulin, a delivery agent that facilitates insulin transport in a therapeutically effective amount to the bloodstream and a biguanide, such as metformin, are disclosed for oral administration to a patient for the treatment of diabetes. Also disclosed are methods for achieving improved glucose tolerance and glycemic control in a diabetic mammal without any statistically significant increase in weight, risk of hypoglycemia or hyperinsulinemia, and the need for monitoring blood glucose concentrations or HbA1c levels, and methods for reducing the incidence and/or severity of one or more disease states associated with chronic dosing of insulin; for prophylactically sparing (3-cell function or for preventing (3-cell death or dysfunction in a mammal with impaired glucose tolerance or early stage diabetes mellitus; and for long-term protection from developing (or delaying the onset of) overt or insulin dependent diabetes in a mammal with impaired glucose tolerance or early stage diabetes.
    • 公开了包括胰岛素,促进胰岛素以治疗有效量转运至血液的递送剂和双胍,例如二甲双胍的药物剂型,用于口服给患者治疗糖尿病。 还公开了用于在糖尿病哺乳动物中实现改善的葡萄糖耐量和血糖控制的方法,而没有任何统计学上显着的重量增加,低血糖或高胰岛素血症的风险,以及监测血糖浓度或HbA1c水平的需要,以及用于降低发生率和/ 或与慢性给药胰岛素相关的一种或多种疾病状态的严重程度; 用于预防性保护(3细胞功能或用于预防(葡萄糖耐量降低或早期糖尿病)的哺乳动物中的3细胞死亡或功能障碍;以及用于长期保护以发展(或延迟发作)明显或胰岛素依赖性 具有葡萄糖耐量降低或早期糖尿病的哺乳动物的糖尿病。
    • 9. 发明申请
    • PALM-CONTROLLED INJECTORS
    • 棕榈控制注射器
    • WO2012135537A2
    • 2012-10-04
    • PCT/US2012/031286
    • 2012-03-29
    • HARISH, ZivRUBINSTEIN, IsaacARBIT, EhudWEINZIMMER, Russ
    • HARISH, ZivRUBINSTEIN, IsaacARBIT, EhudWEINZIMMER, Russ
    • A61M5/24A61M5/20A61M5/14
    • A61M5/2033A61M5/19A61M5/3234A61M5/326A61M5/3287A61M5/422A61M2005/2013A61M2005/206A61M2005/2073
    • A palm-controlled device is disclosed for injection of a substance into an organism. The device includes a palm-receiving surface for receiving a palm of a hand, the palm receiving surface being shaped so that the palm is substantially parallel to a surface of an injection site of the organism while operating the device. The palm receiving surface can also be shaped so that the palm is substantially perpendicular to a surface of the injection site. The device also includes an injector having at least one pre-filled syringe, the palm-receiving surface being cooperative with the injector such that when pressure is applied to the palm-receiving surface, the injector is actuated so as to inject contents of the at least one pre-filled syringe. Actuation of the injector is by gradual pressure; not sudden motion. Single or multiple doses of same or different medications can be included in a single injector.
    • 公开了一种用于将物质注射到生物体中的手掌控制装置。 该装置包括用于接纳手掌的手掌接收表面,手掌接收表面被成形为使得手掌在操作装置时基本上平行于生物体的注射部位的表面。 手掌接收表面也可以被成形为使得手掌基本垂直于注射部位的表面。 该装置还包括具有至少一个预填充注射器的注射器,手掌接收表面与注射器配合,使得当压力施加到手掌接收表面时,注射器被致动以便注射注射器的内容物 至少一个预充注射器。 喷射器的驱动是通过逐渐的压力来实现的; 不是突然的动作。 单次注射器可以包含一次或多次相同或不同的药物。